Latest Ratios: P/E Ratio 29.3x · EV/EBITDA 27.9x · ROE 25.2%. (1997–2026 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $446M | $317M | $308M | $436M | $401M | $263M | $339M | $252M | $475M | $403M | $401M |
| Enterprise Value | $445M | $316M | $301M | $427M | $400M | $254M | $329M | $245M | $468M | $398M | $392M |
| P/E Ratio → | 29.34 | 20.86 | 20.50 | 25.47 | 17.66 | 18.16 | 28.97 | 17.34 | 32.74 | 28.96 | 30.89 |
| P/S Ratio | 16.92 | 12.04 | 11.92 | 14.64 | 10.48 | 9.76 | 15.86 | 9.92 | 17.94 | 13.49 | 14.14 |
| P/B Ratio | 7.65 | 5.44 | 4.95 | 6.66 | 5.98 | 4.08 | 4.78 | 3.23 | 5.74 | 4.66 | 4.32 |
| P/FCF | 30.80 | 21.91 | 23.63 | 23.94 | 22.09 | 21.91 | 25.48 | 15.92 | 33.55 | 27.69 | 33.78 |
| P/OCF | 26.75 | 19.03 | 21.55 | 23.92 | 21.00 | 21.07 | 25.36 | 15.87 | 33.39 | 26.58 | 32.36 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 12.00 | 11.65 | 14.31 | 10.45 | 9.40 | 15.41 | 9.64 | 17.68 | 13.33 | 13.85 |
| EV / EBITDA | 27.93 | 19.85 | 18.47 | 22.65 | 15.47 | 15.13 | 24.78 | 15.25 | 28.14 | 20.48 | 21.10 |
| EV / EBIT | 27.93 | — | 18.84 | 23.03 | 15.59 | 15.53 | 25.83 | 15.79 | 29.39 | 21.57 | 22.49 |
| EV / FCF | — | 21.84 | 23.08 | 23.40 | 22.02 | 21.10 | 24.75 | 15.46 | 33.07 | 27.36 | 33.09 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.7% | 78.7% | 83.6% | 77.3% | 78.9% | 76.8% | 80.7% | 80.8% | 80.3% | 79.0% | 78.5% |
| Operating Margin | 60.5% | 60.5% | 61.8% | 62.1% | 67.0% | 60.5% | 59.6% | 61.1% | 60.2% | 61.8% | 61.6% |
| Net Profit Margin | 57.7% | 57.7% | 58.2% | 57.5% | 59.3% | 53.8% | 54.7% | 57.2% | 54.8% | 46.6% | 45.7% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 25.2% | 25.2% | 23.6% | 25.8% | 34.5% | 21.4% | 15.7% | 18.1% | 17.1% | 15.5% | 13.5% |
| ROA | 24.4% | 24.4% | 23.0% | 25.2% | 33.2% | 20.7% | 15.4% | 17.8% | 17.0% | 15.4% | 13.3% |
| ROIC | 21.2% | 21.2% | 21.7% | 22.8% | 31.9% | 21.1% | 14.5% | 15.9% | 15.2% | 16.7% | 14.9% |
| ROCE | 26.0% | 26.0% | 24.8% | 27.8% | 38.7% | 23.9% | 17.0% | 19.2% | 18.8% | 20.6% | 18.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | — | — | — |
| Debt / EBITDA | 0.05 | 0.05 | 0.06 | 0.02 | 0.02 | 0.04 | 0.06 | 0.05 | — | — | — |
| Net Debt / Equity | — | -0.02 | -0.11 | -0.15 | -0.02 | -0.15 | -0.14 | -0.09 | -0.08 | -0.06 | -0.09 |
| Net Debt / EBITDA | -0.06 | -0.06 | -0.44 | -0.53 | -0.04 | -0.59 | -0.73 | -0.45 | -0.41 | -0.24 | -0.44 |
| Debt / FCF | — | -0.07 | -0.55 | -0.54 | -0.06 | -0.82 | -0.73 | -0.46 | -0.49 | -0.33 | -0.69 |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — |
Net cash position: cash ($2M) exceeds total debt ($740423)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 28.21 | 28.21 | 28.40 | 32.05 | 16.80 | 16.90 | 23.71 | 43.19 | 32.84 | 33.03 | 32.13 |
| Quick Ratio | 22.00 | 22.00 | 22.03 | 25.14 | 13.30 | 14.82 | 19.92 | 38.31 | 27.73 | 29.35 | 29.06 |
| Cash Ratio | 17.38 | 17.38 | 18.59 | 21.44 | 9.38 | 12.74 | 17.62 | 34.10 | 23.17 | 25.79 | 25.37 |
| Asset Turnover | — | 0.44 | 0.40 | 0.45 | 0.55 | 0.40 | 0.29 | 0.32 | 0.32 | 0.34 | 0.30 |
| Inventory Turnover | 0.79 | 0.79 | 0.57 | 0.95 | 1.26 | 1.23 | 1.06 | 1.26 | 1.22 | 1.72 | 1.81 |
| Days Sales Outstanding | — | 47.25 | 50.63 | 38.51 | 62.24 | 63.63 | 33.56 | 38.69 | 41.30 | 35.31 | 44.29 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 4.3% | 6.1% | 6.3% | 4.4% | 4.8% | 7.3% | 5.7% | 7.7% | 4.1% | 4.8% | 4.8% |
| Payout Ratio | 127.3% | 127.3% | 128.4% | 112.9% | 85.1% | 133.3% | 165.3% | 133.4% | 133.5% | 139.2% | 149.4% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.4% | 4.8% | 4.9% | 3.9% | 5.7% | 5.5% | 3.5% | 5.8% | 3.1% | 3.5% | 3.2% |
| FCF Yield | 3.2% | 4.6% | 4.2% | 4.2% | 4.5% | 4.6% | 3.9% | 6.3% | 3.0% | 3.6% | 3.0% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.3% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 4.3% | 6.1% | 6.3% | 4.4% | 4.8% | 7.4% | 5.7% | 8.0% | 4.1% | 4.8% | 4.8% |
| Shares Outstanding | — | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M |
Stagnant Revenue Growth Profile
According to current market data, NVEC trades at a P/E of 30.63 and a P/S of 17.67, suggesting that investors are pricing the firm as a high-margin IP trust rather than a traditional semiconductor manufacturer, despite the company's recent 1.76% year-over-year revenue growth stagnation.
The elevated P/E ratio relative to the modest growth rate implies that the market assigns significant value to the company's long-term design-win pipeline in medical and industrial sectors. Investors should monitor whether this valuation premium remains sustainable if the company fails to demonstrate a clear path toward accelerating its top-line expansion.
Based on reported figures, NVEC's ROIC has hovered between 3.7% and 6.2% over the last ten quarters, which appears modest given the company's elite gross margins, suggesting that the firm's limited revenue scale prevents it from fully leveraging its specialized fabrication assets for higher returns.
While the company maintains a lean operating structure, the relatively low ROIC indicates that the business is not currently compounding capital at a rate that would justify aggressive reinvestment. This warrants further investigation into whether the firm's capital allocation strategy is optimized for long-term value creation or merely for maintaining current profitability.
As reported in financial statements, NVEC's cash conversion cycle has fluctuated significantly, reaching as high as 602 days in 2026Q1, which suggests that the company's inventory management is heavily influenced by the long-tail nature of its specialized medical and industrial sensor product lifecycles.
The exceptionally high days inventory outstanding (DIO) is a structural reality of the business model rather than an operational failure, reflecting the need to hold specialized components for long-term customer requirements. Analysts should interpret these efficiency metrics in the context of the company's unique, low-volume, high-reliability manufacturing environment.
Based on the latest quarterly filings, NVEC maintains a current ratio of 28.21, providing an immense liquidity buffer that, as reported in historical balance sheets, effectively insulates the company from short-term operational shocks or sudden downturns in the broader industrial capital expenditure cycle.
This liquidity position is exceptionally strong compared to semiconductor peers, effectively eliminating any near-term refinancing or solvency risk. Investors should view this as a defensive characteristic that allows the company to maintain its dividend policy even during periods of cyclical revenue contraction.
The PEG ratio of 5.73 is frequently misapplied to NVEC, as it incorrectly assumes that the company's value is derived from rapid revenue growth rather than the durability of its high-margin, long-lifecycle IP, which is better captured by analyzing free cash flow yield.
Using growth-based valuation metrics for a company that prioritizes capital preservation and dividends over expansion leads to an inaccurate assessment of its investment profile. Analysts should instead focus on the stability of the company's operating margins and its ability to generate consistent cash flow from its existing design-win base.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NVEC stock.
NVE Corporation's current P/E ratio is 29.3x. The historical average is 32.8x. This places it at the 74th percentile of its historical range.
NVE Corporation's current EV/EBITDA is 27.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 19.8x.
NVE Corporation's return on equity (ROE) is 25.2%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 10.8%.
Based on historical data, NVE Corporation is trading at a P/E of 29.3x. This is at the 74th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
NVE Corporation's current dividend yield is 4.34% with a payout ratio of 127.3%.
NVE Corporation has 78.7% gross margin and 60.5% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
NVE Corporation's Debt/EBITDA ratio is 0.0x, indicating low leverage. A ratio below 2x is generally considered financially healthy.